Similarly, a better understanding of which patients took compounded GLP-1s could help marketers better understand how patients experiences with compounded medications may influence their future treatment decisions, adherence, and perception of branded medications
#PartD #Formularies #MFP To view or add a comment, sign in Great insights on payers formulary strategy on first years MFP drugs
It addresses the national discussion surrounding the GLP-1 medication shortage (e.g., Ozempic, Wegovy, Saxenda, Mounjaro, Zepbound) and alternative options like compounded formularies from 503A and 503B pharmacies.
By taking the negative logarithm of the p -values from the enrichment analysis and filtering for pathways significantly enriched in both the transcriptomic and proteomic data, key pathways such as protein digestion and absorption and the PI3K-Akt signaling pathway were identified
In addition, despite addressing the degradation on production, the peptide component of this IL17A/IL-22 fusion was still prone to cleavage after in vivo administration 31
